查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1426445

2024 年凝血产品全球市场报告

Hemostasis Products Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年凝血产品市场规模将显着成长。预计到 2028 年将以 6.2% 的复合年增长率 (CAGR) 增长至 21.6 亿美元。预测期内的增长归因于微创手术需求的增加、全球创伤病例的增加、慢性病止血应用的扩大、向门诊手术中心的转变以及对个性化医疗和生物标誌物研究的关注。预测期内预计的主要趋势包括止血创新、止血技术进步、对微创手术的日益偏好、慢性病发病率的增加以及对生物分解性止血剂的日益关注等。

血液疾病盛行率的预期增加预计将在不久的将来推动凝血产品市场的成长。血液疾病或血液疾病包括影响血液及其成分的成分、功能和行为的多种医疗状况。凝血产品在管理与各种血液疾病相关的凝血和出血过程、解决过度出血（出血）和过度凝血（血栓症）方面发挥重要作用。根据白血病基金会 2021年6月的报告，由于该国血癌和血液疾病发生率上升，2021年澳洲将有约11万人患有血液疾病，到2035年这一数字将上升至27.5 万人。2020 .因此，血液疾病盛行率的增加是推动凝血产品市场成长的主要驱动力。

心臟病患病率的预期增加预计将显着促进凝血产品市场的成长。心臟病包括影响心臟和血管的一大类医疗状况。凝血产品在治疗与心臟疾病相关的出血以及预防和治疗此类疾病方面发挥着重要作用。透过最大限度地减少失血，这些产品减少了输血的需要以及与心臟疾病相关的潜在併发症。根据美国疾病管制与预防中心（CDC）2023年5月的数据，在美国每40秒就会发生一次心臟病发作，每年有805,000名美国人经历心臟病发作；一个人正面临第一次癫痫发作。因此，心臟疾病盛行率的增加是推动凝血产品市场成长的关键驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球凝血产品市场，依产品、性能及预测细分，2018-2023、2023-2028、2033
  • 局部凝血产品
  • 输注凝血产品
  • 先进的凝血产品
  • 全球凝血产品市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 创伤
  • 外科手术
  • 血友病
  • 心肌梗塞
  • 其他用途
  • 全球凝血产品市场，按最终用户细分、绩效和预测，2018-2023、2023-2028、2033
  • 医院
  • 诊所
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球凝血产品市场，按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球凝血产品市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 凝血产品市场竞争形势
  • 凝血产品市场公司概况
    • Pfizer Inc.
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc.
    • Medtronic plc
    • Johnson And Johnson Pvt. Ltd.

第31章 其他大型创新公司

  • Siemens Healthineers
  • Becton Dickinson and Company（BD）
  • Stryker Corporation
  • Baxter International Inc.
  • Boston Scientific Corporation
  • F. Hoffmann-La Roche Ltd.
  • BBraun Melsungen AG
  • Fresenius Kabi AG
  • Zimmer Biomet Holdings Inc.
  • Olympus Corporation
  • Grifols SA
  • Terumo BCT Inc.
  • Smith And Nephew plc
  • Ethicon Suture Laboratories
  • Hologic Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r13457

Hemostasis products are medical substances or devices employed to control bleeding and facilitate clotting (hemostasis) across diverse medical contexts. These products play a critical role in the management of bleeding disorders, promotion of wound healing, and ensuring the proper functioning of the body's clotting mechanisms.

The primary categories of hemostasis products include topical hemostasis products, infusible hemostasis products, and advanced hemostasis products. Topical hemostasis products encompass medical substances or materials specifically designed to halt or regulate bleeding. They find applications in various scenarios such as trauma, surgery, hemophilia, myocardial infarction, and others, with major end-users including hospitals, clinics, and others.

The hemostasis products market research report is one of a series of new reports from The Business Research Company that provides hemostasis products market statistics, including hemostasis products industry global market size, regional shares, competitors with a hemostasis products market share, detailed hemostasis products market segments, market trends and opportunities, and any further data you may need to thrive in the hemostasis products industry. This hemostasis products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostasis products market size has grown strongly in recent years. It will grow from $1.59 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth observed in the historical period can be attributed to an increase in surgical procedures, a growing aging population, a rise in the incidence of hemophilia, the expansion of healthcare infrastructure, and an increased awareness of blood clotting disorders.

The hemostasis products market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth in the forecast period can be attributed to the increasing demand for minimally invasive surgeries, a global rise in trauma cases, the expansion of hemostasis applications in chronic diseases, a shift towards ambulatory surgical centers, and the focus on personalized medicine and biomarker research. Key trends expected in the forecast period include technological innovations in hemostasis, advancements in hemostatic technologies, a growing preference for minimally invasive procedures, an increasing incidence of chronic diseases, and a heightened focus on biodegradable hemostatic agents.

The expected increase in the prevalence of blood disorders is poised to drive the growth of the hemostasis products market in the foreseeable future. Blood disorders, or hematologic disorders, encompass various medical conditions affecting the composition, function, and behavior of blood and its components. Hemostasis products play a crucial role in managing clotting and bleeding processes associated with different blood disorders, addressing both excessive bleeding (hemorrhage) and excessive clotting (thrombosis). According to the Leukemia Foundation's June 2021 report, approximately 110,000 people in Australia were living with blood disorders in 2021, a number expected to surpass 275,000 cases by 2035 due to the rising incidence of blood cancer and disorders in the country. Thus, the growing prevalence of blood disorders is a key driver fueling the growth of the hemostasis products market.

The anticipated rise in the prevalence of cardiac disorders is expected to contribute significantly to the growth of the hemostasis products market. Cardiac disorders encompass a broad category of medical conditions affecting the heart and blood vessels. Hemostasis products play a vital role in managing bleeding associated with cardiac disorders and in preventing and treating such conditions. By minimizing blood loss, these products reduce the need for blood transfusions and potential complications related to cardiac disorders. According to the Centers for Disease Control and Prevention (CDC) in May 2023, a heart attack occurs every 40 seconds in the United States, with 805,000 Americans experiencing a heart attack each year, 605,000 of whom are facing their first episode. Therefore, the increasing prevalence of cardiac disorders is a significant driver propelling the growth of the hemostasis products market.

The hemostasis products market is expected to encounter a notable challenge in the form of off-label product usage. This practice involves utilizing hemostatic products for purposes beyond their approved indications, potentially introducing risks and uncertainties in hemostatic treatment. Off-label marketing, as highlighted by the National Library of Medicine, undermines innovation by allowing manufacturers to expand product usage without the necessary research or safety testing. This practice may pose challenges to companies that diligently conduct research and development efforts. Consequently, off-label product usage poses a hindrance to the growth of the hemostasis products market.

Major companies in the hemostasis products market are focusing on the development of innovative drugs, including the Nexpowder endoscopic hemostasis system, and obtaining approvals for a comprehensive range of active and passive hemostatic products for bleeding control. The endoscopic hemostasis system is a medical device and technique used to control bleeding in the gastrointestinal (GI) tract during endoscopic procedures. Medtronic plc, a US-based medical device company, received clearance from the U.S. Food and Drug Administration in September 2022 for the Nexpowder Endoscopic Hemostasis System, designed for the treatment of nonvariceal upper GI bleeding. This innovative hemostatic product has the potential to make a significant impact on the treatment of nonvariceal upper GI bleeding due to its ease of use, effectiveness, and good tolerability.

In July 2021, Baxter International Inc., a US-based healthcare company, acquired assets such as the Polysaccharide Hemostatic System from CryoLife Inc. for $60.8 million. This strategic acquisition aims to expand Baxter's hemostasis product portfolio, gain access to PerClot's technology, and enhance its position in the hemostasis market. CryoLife Inc., a US-based medical device company, specializes in developing and manufacturing products for hemostasis.

Major companies operating in the hemostasis products market report are Pfizer Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Medtronic plc, Johnson And Johnson Pvt. Ltd., Siemens Healthineers, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., BBraun Melsungen AG, Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Grifols S.A., Terumo BCT Inc., Smith And Nephew plc, Ethicon Suture Laboratories, Hologic Inc., Cook Medical, Teleflex Incorporated, Integra LifeSciences Corporation, Haemonetics Corporation, Z-Medica LLC, Tricol Biomedical, Hem Con Medical Technologies Inc., Hemostasis LLC, C. R. Bard Inc., CuraMedical BV

North America was the largest region in the hemostasis products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostasis products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hemostasis products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hemostasis products market consists of sales of hemostatic agents, hemostatic powders, hemostatic sponges, collagen, oxidized regenerated cellulose, gelatin, polysaccharide, flowable complex, thrombin complex, fibrin complex, synthetic sealants, and fresh frozen plasma. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostasis Products Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostasis products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostasis products? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemostasis products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Topical Hemostasis Product; Infusible Hemostasis Product; Advanced Hemostasis Product
  • 2) By Application: Trauma; Surgery; Hemophilia; Myocardial Infarction; Other Applications
  • 3) By End User: Hospitals; Clinics; Other End Users
  • Companies Mentioned: Pfizer Inc.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Medtronic plc; Johnson And Johnson Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemostasis Products Market Characteristics

3. Hemostasis Products Market Trends And Strategies

4. Hemostasis Products Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Hemostasis Products Market Size and Growth

  • 5.1. Global Hemostasis Products Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hemostasis Products Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hemostasis Products Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hemostasis Products Market Segmentation

  • 6.1. Global Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Topical Hemostasis Product
  • Infusible Hemostasis Product
  • Advanced Hemostasis Product
  • 6.2. Global Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Trauma
  • Surgery
  • Hemophilia
  • Myocardial Infarction
  • Other Applications
  • 6.3. Global Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Other End Users

7. Hemostasis Products Market Regional And Country Analysis

  • 7.1. Global Hemostasis Products Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hemostasis Products Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hemostasis Products Market

  • 8.1. Asia-Pacific Hemostasis Products Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hemostasis Products Market

  • 9.1. China Hemostasis Products Market Overview
  • 9.2. China Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hemostasis Products Market

  • 10.1. India Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hemostasis Products Market

  • 11.1. Japan Hemostasis Products Market Overview
  • 11.2. Japan Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hemostasis Products Market

  • 12.1. Australia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hemostasis Products Market

  • 13.1. Indonesia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hemostasis Products Market

  • 14.1. South Korea Hemostasis Products Market Overview
  • 14.2. South Korea Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hemostasis Products Market

  • 15.1. Western Europe Hemostasis Products Market Overview
  • 15.2. Western Europe Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hemostasis Products Market

  • 16.1. UK Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hemostasis Products Market

  • 17.1. Germany Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hemostasis Products Market

  • 18.5. France Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hemostasis Products Market

  • 19.9. Italy Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hemostasis Products Market

  • 20.13. Spain Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hemostasis Products Market

  • 21.1. Eastern Europe Hemostasis Products Market Overview
  • 21.2. Eastern Europe Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hemostasis Products Market

  • 22.1. Russia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hemostasis Products Market

  • 23.1. North America Hemostasis Products Market Overview
  • 23.2. North America Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hemostasis Products Market

  • 24.1. USA Hemostasis Products Market Overview
  • 24.2. USA Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hemostasis Products Market

  • 25.1. Canada Hemostasis Products Market Overview
  • 25.2. Canada Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hemostasis Products Market

  • 26.1. South America Hemostasis Products Market Overview
  • 26.2. South America Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hemostasis Products Market

  • 27.1. Brazil Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hemostasis Products Market

  • 28.1. Middle East Hemostasis Products Market Overview
  • 28.2. Middle East Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hemostasis Products Market

  • 29.1. Africa Hemostasis Products Market Overview
  • 29.2. Africa Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hemostasis Products Market Competitive Landscape And Company Profiles

  • 30.1. Hemostasis Products Market Competitive Landscape
  • 30.2. Hemostasis Products Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Medtronic plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Johnson And Johnson Pvt. Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Hemostasis Products Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers
  • 31.2. Becton Dickinson and Company (BD)
  • 31.3. Stryker Corporation
  • 31.4. Baxter International Inc.
  • 31.5. Boston Scientific Corporation
  • 31.6. F. Hoffmann-La Roche Ltd.
  • 31.7. BBraun Melsungen AG
  • 31.8. Fresenius Kabi AG
  • 31.9. Zimmer Biomet Holdings Inc.
  • 31.10. Olympus Corporation
  • 31.11. Grifols S.A.
  • 31.12. Terumo BCT Inc.
  • 31.13. Smith And Nephew plc
  • 31.14. Ethicon Suture Laboratories
  • 31.15. Hologic Inc.

32. Global Hemostasis Products Market Competitive Benchmarking

33. Global Hemostasis Products Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hemostasis Products Market

35. Hemostasis Products Market Future Outlook and Potential Analysis

  • 35.1 Hemostasis Products Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Hemostasis Products Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Hemostasis Products Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer